United Kingdom · Question · Written question
UIN 79292
Coronavirus: Vaccination
Introduced
22 November 2021
Last action
26 January 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
26 January 2022
Summary
To ask the Secretary of State for Health and Social Care, when he expects the MHRA to license a covid-19 nasal vaccine; and whether approval of nasal vaccines will be fast-tracked in line with injectable covid-19 vaccines; and if he will make a statement.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 November 2021
Written question
To ask the Secretary of State for Health and Social Care, when he expects the MHRA to license a covid-19 nasal vaccine; and whether approval of nasal vaccines will be fast-tracked in line with injectable covid-19 vaccines; and if he will make a statement.
Source: Commons
26 January 2022
Answer
Any route to approval of nasal vaccine treatments is subject to the developer seeking regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA is therefore unable to provide a timetable for the approval of a COVID-...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-11-22/79292
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1381000
- uk · wq-1381000 · source updated 26 January 2022